IDEX CORP /DE/

Listed Company

IEXCIK 0000832101NYSELarge AcceleratedPumps & Pumping EquipmentDelawareFY ends Dec 31

Period

FY 2025

Revenue

$3.46B

Net Income

$483.20M

Total Assets

$6.93B

Equity

$4.03B

Shares Out

74.02M

Op. Cash Flow

$680.40M

IEX$225.00+22.34% · past yearDBEQ Basic

Daily closing prices

Business

IDEX Corporation is a global applied solutions provider serving niche markets with mission-critical components through over 50 wholly-owned subsidiaries. The company designs, manufactures and distributes precision pumps, fluidics, sealing solutions, pneumatic components, optical systems, material processing equipment, flow control products, firefighting equipment, rescue tools and specialty dispensing systems. IDEX operates through three reportable segments: Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety/Diversified Products, serving industrial, life sciences, energy, water, fire suppression, semiconductor, automotive, aviation, chemical and food & beverage markets globally with manufacturing and distribution facilities in over 20 countries.

Summary from 10-K filed 2026-02-19

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net sales	3,458	3,269	3,274	3,182	2,765
Cost of sales	1,919	1,824	1,827	1,755	1,540
Gross profit	1,539	1,445	1,447	1,427	1,225
Selling, general and administrative expenses	819	759	704	653	578
Restructuring expenses and asset impairments	21	9	11	23	9
Operating income	699	677	733	751	637
Gain on sale of businesses net	0	−4	−85	−35	0
Other expense (income) net	2	−3	5	−4	16
Interest expense - net	64	45	52	41	—
Income before income taxes	633	639	760	749	580
Provision for income taxes	150	135	165	163	131
Net income	483	505	596	587	449
Net loss attributable to noncontrolling interest	700,000	400,000	500,000	200,000	100,000
Net income attributable to IDEX	483	505	596	587	449
Basic earnings per common share attributable to IDEX (in dollar per share)	6.41	6.66	7.87	7.74	5.91
Diluted earnings per common share attributable to IDEX (in dollar per share)	6.41	6.64	7.85	7.71	5.88
Basic weighted average common shares outstanding (in shares)	75	76	76	76	76
Diluted weighted average common shares outstanding (in shares)	75	76	76	76	76

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	580	621	534	430	855
Receivables net	522	466	428	443	356
Inventories net	479	430	421	471	370
Other current assets	62	76	63	55	96
Total current assets	1,643	1,593	1,446	1,399	1,678
Property, plant and equipment net	468	460	430	382	327
Goodwill	3,415	3,252	2,838	2,638	2,168
Intangible assets net	1,247	1,285	1,012	948	597
Other noncurrent assets	154	156	139	145	147
Total assets	6,927	6,745	5,865	5,512	4,917
Trade accounts payable	225	198	180	209	179
Accrued expenses	297	279	272	289	260
Current portion of long-term borrowings	700,000	101	600,000	0	—
Dividends payable	53	53	49	46	41
Total current liabilities	575	630	500	544	480
Long-term borrowings net	1,820	1,860	1,325	1,469	1,190
Deferred income taxes	303	267	292	264	196
Other noncurrent liabilities	202	195	207	196	247
Total liabilities	2,901	2,951	2,324	2,472	2,114
Commitments and contingencies (Note 10)	—	—	—	—	—
Authorized: 5.0 million shares, $0.01 per share par value; Issued: None	0	0	0	0	0
Authorized: 150.0 million shares, $0.01 per share par value Issued: 90.1 million shares at both December 31, 2025 and 2024	900,000	900,000	900,000	900,000	900,000
Treasury stock at cost: 15.5 million shares at December 31, 2025 and 14.2 million shares at December 31, 2024	−1,423	−1,170	−1,187	−1,184	—
Additional paid-in capital	892	865	839	817	796
Retained earnings	4,500	4,230	3,934	3,532	3,127
Accumulated other comprehensive income (loss)	58	−131	−46	−126	−70
Total shareholders equity	4,028	3,795	3,541	3,039	2,803
Noncontrolling interest	−1	−600,000	−200,000	300,000	0
Total equity	4,026	3,794	3,541	3,040	2,803
Total liabilities and equity	6,927	6,745	5,865	5,512	4,917

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Asset Impairments	700,000	100,000	800,000	17	—
Credit loss on note receivable from collaborative partner	0	0	8	0	0
Depreciation	76	69	57	51	47
Amortization of intangible assets	131	107	95	69	56
Share-based compensation expense	27	26	22	22	20
Deferred income taxes	13	−19	−15	−19	−6
Receivables net	−41	−17	21	−72	−49
Inventories net	−34	18	66	−72	−46
Other current assets	2	−100,000	−7	−500,000	9
Trade accounts payable	15	9	−25	18	23
Deferred revenue	3	−18	13	−25	20
Accrued expenses	2	−9	−35	17	26
Other net	5	2	5	700,000	4
Net cash flows provided by operating activities	680	668	717	557	565
Capital expenditures	−64	−65	−90	−68	−73
Acquisition of businesses, net of cash acquired	−76	−985	−312	−946	−577
Proceeds from sale of businesses, net of cash remitted	0	45	119	49	0
Purchase of marketable securities	0	0	−29	0	−45
Proceeds from sale of marketable securities	0	5	25	40	0
Other net	2	−7	4	7	−3
Net cash flows used in investing activities	−138	−1,007	−284	−917	−698
Borrowings under revolving credit facilities	252	279	0	210	0
Payments under revolving credit facilities	−323	−69	0	−135	0
Proceeds from issuance of long-term borrowings	0	497	100	200	499
Payment of long-term borrowings	−100	−50	−250	0	−350
Cash dividends paid to shareholders	−213	−205	−191	−177	−161
(Payments) proceeds from share issuances, net of shares withheld for taxes	−500,000	17	22	—	—
Repurchases of common stock	−248	0	−24	−148	0
Other net	−800,000	−2	−1	−2	−5
Net cash flows (used in) provided by financing activities	−633	466	−345	−38	−10
Effect of exchange rate changes on cash and cash equivalents	37	−23	16	−28	−28
Net (decrease) increase in cash and cash equivalents and restricted cash	−53	105	104	−425	−171
Interest	72	47	51	37	36
Income taxes - net	135	171	200	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is IDEX CORP /DE/'s CIK number?

IDEX CORP /DE/'s SEC CIK number is 0000832101 (832101). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find IDEX CORP /DE/'s SEC filings?

All of IDEX CORP /DE/'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did IDEX CORP /DE/ last report earnings?

IDEX CORP /DE/ (IEX) most recently filed an earnings 8-K with the SEC on Apr 29, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0000832101-26-000007). This is IDEX CORP /DE/'s most recent earnings filing of record — not a forecast of its next earnings date.

What is IDEX CORP /DE/'s most recent earnings 8-K?

IDEX CORP /DE/'s latest earnings 8-K (Item 2.02) was filed Apr 29, 2026 under accession 0000832101-26-000007. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View IDEX CORP /DE/'s latest earnings 8-K →
Look up any company's CIK number →